Wellness Franchise Opportunities

NeurologistMar, 21 2015

International neurologist Dr Michael Chez joins Indian Cordlife campaign to combat autism

Indian stem cell bank Cordlife has been joined by international autism and epilepsy treatment pioneer Dr Michael Chez from Sutter Neuroscience Institute in USA, to find out treatment of childhood autism using cord blood stem cells.

By WI Bureau

Autism, a complex neuro development disorder that manifests in children by the age of three, may vary from mild to very severe and is hence, known as Autism Spectrum Disorder.

According to a ToI report, the prevalence rate of autism in India is 1 in 250 (figure may vary as many cases are not diagnosed) and presently, about 10 million people are suffering with the disease in India.

The government only recognised the disorder in 2001, till 1980s, there were reports that Autism didn't exist in India. But now, the Indian government recognises it as a disability.

Various Indian neuro-healthcare institutes are making every possible efforts to spread awareness about the disease and research is on to combat it completely.

Joining the same, Dr Michael Chez, a leading international neurologist from Sutter Neuroscience Institute in USA, has recently partnered with a team of Indian doctors at stem cell bank, Cordlife to find out the treatment of childhood autism using cord blood stem cells.

Commenting on her aim, Dr Chez, said that are a number of research studies being undertaken worldwide to investigate the effects of cord blood stem cells that can potentially restore brain function in people with similar disorders.

He further added that the therapy can potentially decrease disabilities and improve quality of life for millions, if successful.

In India, he was collaborating with physicians to perform pioneering use of the patient's own cord blood stem cells for the treatment of childhood autism.

 

Significantly, Cord blood that remains in the umbilical cord and placenta following the birth of a newborn is a rich source of hematopoietic stem cells, which has proven benefits and is useful in the treatment of over 80 diseases including certain cancers and blood disorders.

 

image curtesy: Facebook

Related: Apollo to increase bedcount to 9,000 by 2017

Click Here to add Comment
Please add your Comment
Rating
Sell Business 2017
Sell Franchise 2017

Newsletter Signup

Submit your email address to receive the latest updates on news & host of opportunities from Wellness India.

Video

Magazines & Books

Read the latest franchising magazines and books to get comprehensive and up-to-date information on leading franchise systems, trends and more.


Newsletter Signup
Submit your email address to receive the latest updates on news & host of opportunities.
Well Ness India

Copyright © 2009 - 2017 Franchise India Holdings Ltd.

The information contained herein is of generic nature only, and Franchise India is not, by means of this website or any part thereof, rendering professional advice or services. Before making any decision or taking any action that might affect your finances or business, you should consult a qualified professional advisor. Your use of this website or any of its pages or links given, is at your own risk and you assume full responsibility and risk of loss resulting from your usage. With respect to use of the website, kindly visit www.franchiseindia.com/terms.